Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
ABI: 2025 International North American Insolvency Symposium (New York/ Skadden)
ABI: 2025 International North American Insolvency Symposium (New York/ Skadden)
ABI’s International Committee is pleased to present the 2025 International North American Insolvency Symposium, which will be held at the offices of Skadden, Arps, Slate, Meagher & Flom LLP in Midtown Manhattan. Formerly known as ABI’s Cross-Border Insolvency Program, this annual day-long conference features a unique gathering of speakers from several nations, who will be…
1 event,
Octus: LME’d, Now What? (Webinar)
Octus: LME’d, Now What? (Webinar)
What happens after a company has executed a liability management exercise? Join Octus on Thursday, November 6, at 11 a.m. ET, for a 45-minute webinar discussion of post-LME lender considerations. Topics discussed will include how lenders can navigate tighter post-LME debt documents should borrowers continue to struggle, and the dynamics of cooperation and other agreements…
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
Octus: Clarity in the Cap Stack: CLO performance in 2025 (Webinar)
Octus: Clarity in the Cap Stack: CLO performance in 2025 (Webinar)
Join Octus on Thursday, November 13 at 11 a.m. ET for an expert panel discussion on the CLO market. We will analyze a volatile 2025, covering its key credit events, shifting investor demand, issuance trends, and loan supply. Our panelists will then provide their expert outlook for the CLO market in 2026, offering key insights…
0 events,
0 events,
0 events,
0 events,
1 event,
NCBJ: Healthcare Bankruptcies: Complex Diagnosis, Difficult to Treat
NCBJ: Healthcare Bankruptcies: Complex Diagnosis, Difficult to Treat
The panel will discuss the role of regulators in various aspects of healthcare bankruptcies, including sales, reorganization and liquidation; issues concerning real property leases, including sale-leaseback structures; difficulties of valuing healthcare companies in the context of sales and reorganization; and issues arising in Chapter 7 cases of health care businesses.